2nd Quarter - Amendment — PFIZER INC. for PFIZER INC. (2015)

Firm

PFIZER INC.

Client

PFIZER INC.

Income

—

Expenses

$1,750,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
2nd Quarter - Report	Jul 21, 2015	$1,780,000	Replaced
2nd Quarter - Amendment (this page)	Jul 21, 2015	$1,750,000	Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Algeria Pricing Issues Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Vietnam Distribution Trade Adjustment Assistance

Lobbyist	Covered position, as disclosed
PAULA BURG	—
KEN W COLE	—
DOUGLAS REID GOUDIE	—
JOHN PAUL HALLIWELL	—
ANGELA WALKER RIEMER	—
MARY BRIDGET WALSH	—
JENNIFER SWENSON WALTON	—

Contacted: State, Dept of (DOS); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Natl Security Council (NSC); Treasury, Dept of; Food & Drug Administration (FDA); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box

Lobbyist	Covered position, as disclosed
PAULA BURG	—
KEN W COLE	—
JOHN PAUL HALLIWELL	—
ANGELA WALKER RIEMER	—
CAROLINE MOODY SCHELLHAS	—
MARY BRIDGET WALSH	—
JENNIFER SWENSON WALTON	—

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Commerce, Dept of (DOC); Treasury, Dept of

Health Issues HCR

FDA Funding HHS Appropriations 340B Antibiotics Dormant Therapies FDA Breakthrough Therapies 21st Century Cures Initiative Senate Innovation Project

Lobbyist	Covered position, as disclosed
PAULA BURG	—
KEN W COLE	—
JOHN PAUL HALLIWELL	—
ANGELA WALKER RIEMER	—
MARY BRIDGET WALSH	—
JENNIFER SWENSON WALTON	—

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; Natl Economic Council (NEC); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Treasury, Dept of; Food & Drug Administration (FDA)

Copyright/Patent/Trademark CPT

Patent Troll Legislation

Lobbyist	Covered position, as disclosed
PAULA BURG	—
KEN W COLE	—
JOHN PAUL HALLIWELL	—
ANGELA WALKER RIEMER	—
MARY BRIDGET WALSH	—
JENNIFER SWENSON WALTON	—

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Food & Drug Administration (FDA); Treasury, Dept of; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Commerce, Dept of (DOC); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Natl Economic Council (NEC)

Alcohol and Drug Abuse ALC

STOPPAct (Stop the Tampering of Prescription Pills)

Lobbyist	Covered position, as disclosed
ANGELA WALKER RIEMER	—

Contacted: Natl Security Council (NSC); Natl Economic Council (NEC); Treasury, Dept of; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Patent & Trademark Office (PTO); SENATE; State, Dept of (DOS); U.S. Trade Representative (USTR)

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations IPAB

Lobbyist	Covered position, as disclosed
PAULA BURG	—
JOHN PAUL HALLIWELL	—
ANGELA WALKER RIEMER	—

Contacted: Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Treasury, Dept of; State, Dept of (DOS); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Preventing Abuse of Cough Treatment Act

Lobbyist	Covered position, as disclosed
ANGELA WALKER RIEMER	—

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Natl Economic Council (NEC); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Treasury, Dept of; Executive Office of the President (EOP); Natl Security Council (NSC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.